Qualification of Drivers; Exemption Applications; Diabetes Mellitus, 19798-19799 [2013-07459]
Download as PDF
19798
Federal Register / Vol. 78, No. 63 / Tuesday, April 2, 2013 / Notices
this purpose, such application services
include, but are not limited to,
appointment management, fee
collection, document delivery, and the
collection of biometric data from
applicants.
Additionally, I hereby determine the
provision of such application services
by private entities for foreign missions
in the United States to be subject to
such terms and conditions as may be
established by the Department’s Office
of Foreign Missions and that any state
or local laws to the contrary are hereby
preempted.
In accordance with § 211(a) of the Act,
it shall be unlawful for any person to
make available any benefits to a foreign
mission that are contrary to the Act. The
United States, acting on its own behalf
or on behalf of a foreign mission, has
standing to bring or intervene in an
action to obtain compliance with this
chapter, including any action for
injunctive or other equitable relief.
Dated: March 18th, 2013.
Patrick F. Kennedy,
Under Secretary for Management.
[FR Doc. 2013–07628 Filed 4–1–13; 8:45 am]
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[FMCSA Docket No. FMCSA–2013–0011]
Qualification of Drivers; Exemption
Applications; Diabetes Mellitus
Federal Motor Carrier Safety
Administration (FMCSA), DOT.
ACTION: Notice of final disposition.
AGENCY:
FMCSA announces its
decision to exempt 19 individuals from
its rule prohibiting persons with
insulin-treated diabetes mellitus (ITDM)
from operating commercial motor
vehicles (CMVs) in interstate commerce.
The exemptions will enable these
individuals to operate CMVs in
interstate commerce.
DATES: The exemptions are effective
April 2, 2013. The exemptions expire on
April 2, 2015.
FOR FURTHER INFORMATION CONTACT:
Elaine M. Papp, Chief, Medical
Programs Division, (202) 366–4001,
fmcsamedical@dot.gov, FMCSA, Room
W64–224, Department of
Transportation, 1200 New Jersey
Avenue SE., Washington, DC 20590–
0001. Office hours are from 8:30 a.m. to
5 p.m., Monday through Friday, except
Federal holidays.
SUPPLEMENTARY INFORMATION:
srobinson on DSK4SPTVN1PROD with NOTICES
VerDate Mar<15>2010
19:35 Apr 01, 2013
Jkt 229001
You may see all the comments online
through the Federal Document
Management System (FDMS) at: https://
www.regulations.gov.
Docket: For access to the docket to
read background documents or
comments, go to https://
www.regulations.gov and/or Room
W12–140 on the ground level of the
West Building, 1200 New Jersey Avenue
SE., Washington, DC, between 9 a.m.
and 5 p.m., Monday through Friday,
except Federal holidays.
Privacy Act: Anyone may search the
electronic form of all comments
received into any of DOT’s dockets by
the name of the individual submitting
the comment (or of the person signing
the comment, if submitted on behalf of
an association, business, labor union, or
other entity). You may review DOT’s
Privacy Act Statement for the Federal
Docket Management System (FDMS)
published in the Federal Register on
December 29, 2010 (75 FR 82132), or
you may visit https://www.gpo.gov/fdsys/
pkg/FR-2010-12-29/pdf/2010-32876.pdf.
Background
BILLING CODE 4710–43–P
SUMMARY:
Electronic Access
On February 4, 2013, FMCSA
published a notice of receipt of Federal
diabetes exemption applications from
19 individuals and requested comments
from the public (78 FR 7852). The
public comment period closed on March
6, 2013, and no comments were
received.
FMCSA has evaluated the eligibility
of the 19 applicants and determined that
granting the exemptions to these
individuals would achieve a level of
safety equivalent to or greater than the
level that would be achieved by
complying with the current regulation
49 CFR 391.41(b)(3).
Diabetes Mellitus and Driving
Experience of the Applicants
The Agency established the current
requirement for diabetes in 1970
because several risk studies indicated
that drivers with diabetes had a higher
rate of crash involvement than the
general population. The diabetes rule
provides that ‘‘A person is physically
qualified to drive a commercial motor
vehicle if that person has no established
medical history or clinical diagnosis of
diabetes mellitus currently requiring
insulin for control’’ (49 CFR
391.41(b)(3)).
FMCSA established its diabetes
exemption program, based on the
Agency’s July 2000 study entitled ‘‘A
Report to Congress on the Feasibility of
a Program to Qualify Individuals with
Insulin-Treated Diabetes Mellitus to
PO 00000
Frm 00162
Fmt 4703
Sfmt 4703
Operate in Interstate Commerce as
Directed by the Transportation Act for
the 21st Century.’’ The report concluded
that a safe and practicable protocol to
allow some drivers with ITDM to
operate CMVs is feasible. The
September 3, 2003 (68 FR 52441),
Federal Register notice in conjunction
with the November 8, 2005 (70 FR
67777), Federal Register notice provides
the current protocol for allowing such
drivers to operate CMVs in interstate
commerce.
These 19 applicants have had ITDM
over a range of 4 to 44 years. These
applicants report no severe
hypoglycemic reactions resulting in loss
of consciousness or seizure, requiring
the assistance of another person, or
resulting in impaired cognitive function
that occurred without warning
symptoms, in the past 12 months and no
recurrent (2 or more) severe
hypoglycemic episodes in the past 5
years. In each case, an endocrinologist
verified that the driver has
demonstrated a willingness to properly
monitor and manage his/her diabetes
mellitus, received education related to
diabetes management, and is on a stable
insulin regimen. These drivers report no
other disqualifying conditions,
including diabetes-related
complications. Each meets the vision
requirement at 49 CFR 391.41(b)(10).
The qualifications and medical
condition of each applicant were stated
and discussed in detail in the February
4, 2013, Federal Register notice and
they will not be repeated in this notice.
Discussion of Comments
FMCSA received no comments in this
proceeding.
Basis for Exemption Determination
Under 49 U.S.C. 31136(e) and 31315,
FMCSA may grant an exemption from
the diabetes requirement in 49 CFR
391.41(b)(3) if the exemption is likely to
achieve an equivalent or greater level of
safety than would be achieved without
the exemption. The exemption allows
the applicants to operate CMVs in
interstate commerce.
To evaluate the effect of these
exemptions on safety, FMCSA
considered medical reports about the
applicants’ ITDM and vision, and
reviewed the treating endocrinologists’
medical opinion related to the ability of
the driver to safely operate a CMV while
using insulin.
Consequently, FMCSA finds that in
each case exempting these applicants
from the diabetes requirement in 49 CFR
391.41(b)(3) is likely to achieve a level
of safety equal to that existing without
the exemption.
E:\FR\FM\02APN1.SGM
02APN1
Federal Register / Vol. 78, No. 63 / Tuesday, April 2, 2013 / Notices
Conditions and Requirements
The terms and conditions of the
exemption will be provided to the
applicants in the exemption document
and they include the following: (1) That
each individual submit a quarterly
monitoring checklist completed by the
treating endocrinologist as well as an
annual checklist with a comprehensive
medical evaluation; (2) that each
individual reports within 2 business
days of occurrence, all episodes of
severe hypoglycemia, significant
complications, or inability to manage
diabetes; also, any involvement in an
accident or any other adverse event in
a CMV or personal vehicle, whether or
not it is related to an episode of
hypoglycemia; (3) that each individual
provide a copy of the ophthalmologist’s
or optometrist’s report to the medical
examiner at the time of the annual
medical examination; and (4) that each
individual provide a copy of the annual
medical certification to the employer for
retention in the driver’s qualification
file, or keep a copy in his/her driver’s
qualification file if he/she is selfemployed. The driver must also have a
copy of the certification when driving,
for presentation to a duly authorized
Federal, State, or local enforcement
official.
srobinson on DSK4SPTVN1PROD with NOTICES
Conclusion
Based upon its evaluation of the 19
exemption applications, FMCSA
exempts Nicholas C. Bolton (NY), Isaias
Gomez (IN), Brandon E. Hamlett (NV),
Douglas F. Keller (MI), Mark R. Loesel
(WI), Steven A. Marion (MA), Jason E.
McAnnally (AL), Robert W. Moen (IA),
Craig S. Moran (CA), Wayne A.
Ondrusek (PA), Lenicia R. Riley (TX),
Mark L. Sandager (MN), Samuel L.
Sergio (MA), Jason L. Shaw (OK), Paul
M. Shierk (OR), Kailey J. Skroko (IN),
Samantha K. Tsuchiya (CA), David W.
West (MO), and Eugene Zollner, II (OH)
from the ITDM requirement in 49 CFR
391.41(b)(3), subject to the conditions
listed under ‘‘Conditions and
Requirements’’ above.
In accordance with 49 U.S.C. 31136(e)
and 31315 each exemption will be valid
for two years unless revoked earlier by
FMCSA. The exemption will be revoked
if the following occurs: (1) The person
fails to comply with the terms and
conditions of the 1/exemption; (2) the
exemption has resulted in a lower level
of safety than was maintained before it
was granted; or (3) continuation of the
exemption would not be consistent with
the goals and objectives of 49 U.S.C.
31136(e) and 31315. If the exemption is
still effective at the end of the 2-year
period, the person may apply to FMCSA
VerDate Mar<15>2010
19:35 Apr 01, 2013
Jkt 229001
for a renewal under procedures in effect
at that time.
Issued on: March 21, 2013.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2013–07459 Filed 4–1–13; 8:45 am]
BILLING CODE 4910–EX–P
DEPARTMENT OF THE TREASURY
United States Mint
National Baseball Hall of Fame
Commemorative Coin Program Design
Competition
Notification of the Opening of
the National Baseball Hall of Fame
Commemorative Coin Program Design
Competition on April 11, 2013.
ACTION:
The United States Mint
announces the opening of a national
coin design competition that will
culminate in the Secretary of the
Treasury’s selection of the image for the
obverse (heads side) of the 2014
National Baseball Hall of Fame
Commemorative Coins. The
competition, which is open to all United
States citizens and permanent residents
ages 14 and over, begins on April 11,
2013, at 12 noon Eastern Daylight Time
(EDT). The submission period will end
at 12 noon EDT on April 26, 2013, if
10,000 or more entries have been
received by that time. If fewer than
10,000 entries have been received by 12
noon EDT on April 26, 2013, then the
submission period will remain open
until 10,000 entries have been received,
but will end no later than May 11, 2013,
at 12 noon EDT. The winner of the
design competition will be awarded
$5,000, and the winner’s initials will
appear on the minted coins.
The National Baseball Hall of Fame
Commemorative Coin Act (Act), Public
Law 112–152 (Aug. 3, 2012), requires
the Secretary of the Treasury to mint
and issue three 2014 commemorative
coins to recognize and celebrate the
National Baseball Hall of Fame: up to
50,000 $5 gold coins, up to 400,000 $1
silver coins, and up to 750,000 halfdollar clad coins. The Act requires a
competition, which Challenge.gov is
hosting, to select a common obverse
design emblematic of the game of
baseball. Additionally, the Act
expresses Congress’s sense that the $5
gold and $1 silver coins have a shape
such that the obverse is concave and the
reverse is convex.
Entries will be evaluated during a
selection process consisting of an initial
screening for minimum requirements
and four evaluation rounds. The
SUMMARY:
PO 00000
Frm 00163
Fmt 4703
Sfmt 4703
19799
Citizens Coinage Advisory Committee,
the U.S. Commission of Fine Arts, and
the National Baseball Hall of Fame will
review the finalist designs, after which
the United States Mint will put forward
a recommended design to the Secretary
of the Treasury for selection.
Official rules, guidelines, and entry
instructions for the United States Mint
National Baseball Hall of Fame
Commemorative Coin Program Design
Competition can be found at
www.usmint.gov/batterup and at
www.batterup.challenge.gov.
FOR FURTHER INFORMATION CONTACT: The
United States Mint’s Competition
Administrator is Leslie Schwager,
Program Specialist. She can be reached
at baseballcompetition@usmint.treas.
gov.
Authority: National Baseball Hall of Fame
Commemorative Coin Act, Public Law 112–
152.
Dated: March 27, 2013.
David Motl,
Chief Financial Officer, United States Mint.
[FR Doc. 2013–07622 Filed 4–1–13; 8:45 am]
BILLING CODE P
DEPARTMENT OF THE TREASURY
United States Mint
United States Mint Kids’ Baseball Coin
Design Challenge
Notification of the Opening of
the United States Mint Kids’ Baseball
Coin Design Challenge on April 11,
2013.
ACTION:
The United States Mint
announces the opening of a national
kids’ baseball coin design challenge on
April 11, 2013, that seeks design entries
from contestants age 13 years or younger
on the theme, ‘‘What’s Great about
Baseball.’’ As part of the United States
Mint’s education initiative, this
challenge is designed to provide
learning materials for children, teachers,
and parents on the United States Mint
and its coins and medals, to build
awareness of the bureau’s operations
and programs, and to complement the
United States Mint National Baseball
Hall of Fame Commemorative Coin
Program Design Competition, which is a
national competition for individuals 14
or older to create the design for the
common obverse (front) of coins to be
issued under the 2014 National Baseball
Hall of Fame Commemorative Coin
Program.
In creating their design entries,
contestants are allowed to use any
medium—acrylics, watercolor, pencil,
charcoal, marker, spray paint, crayon,
SUMMARY:
E:\FR\FM\02APN1.SGM
02APN1
Agencies
[Federal Register Volume 78, Number 63 (Tuesday, April 2, 2013)]
[Notices]
[Pages 19798-19799]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-07459]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration
[FMCSA Docket No. FMCSA-2013-0011]
Qualification of Drivers; Exemption Applications; Diabetes
Mellitus
AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.
ACTION: Notice of final disposition.
-----------------------------------------------------------------------
SUMMARY: FMCSA announces its decision to exempt 19 individuals from its
rule prohibiting persons with insulin-treated diabetes mellitus (ITDM)
from operating commercial motor vehicles (CMVs) in interstate commerce.
The exemptions will enable these individuals to operate CMVs in
interstate commerce.
DATES: The exemptions are effective April 2, 2013. The exemptions
expire on April 2, 2015.
FOR FURTHER INFORMATION CONTACT: Elaine M. Papp, Chief, Medical
Programs Division, (202) 366-4001, fmcsamedical@dot.gov, FMCSA, Room
W64-224, Department of Transportation, 1200 New Jersey Avenue SE.,
Washington, DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m.,
Monday through Friday, except Federal holidays.
SUPPLEMENTARY INFORMATION:
Electronic Access
You may see all the comments online through the Federal Document
Management System (FDMS) at: https://www.regulations.gov.
Docket: For access to the docket to read background documents or
comments, go to https://www.regulations.gov and/or Room W12-140 on the
ground level of the West Building, 1200 New Jersey Avenue SE.,
Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays.
Privacy Act: Anyone may search the electronic form of all comments
received into any of DOT's dockets by the name of the individual
submitting the comment (or of the person signing the comment, if
submitted on behalf of an association, business, labor union, or other
entity). You may review DOT's Privacy Act Statement for the Federal
Docket Management System (FDMS) published in the Federal Register on
December 29, 2010 (75 FR 82132), or you may visit https://www.gpo.gov/fdsys/pkg/FR-2010-12-29/pdf/2010-32876.pdf.
Background
On February 4, 2013, FMCSA published a notice of receipt of Federal
diabetes exemption applications from 19 individuals and requested
comments from the public (78 FR 7852). The public comment period closed
on March 6, 2013, and no comments were received.
FMCSA has evaluated the eligibility of the 19 applicants and
determined that granting the exemptions to these individuals would
achieve a level of safety equivalent to or greater than the level that
would be achieved by complying with the current regulation 49 CFR
391.41(b)(3).
Diabetes Mellitus and Driving Experience of the Applicants
The Agency established the current requirement for diabetes in 1970
because several risk studies indicated that drivers with diabetes had a
higher rate of crash involvement than the general population. The
diabetes rule provides that ``A person is physically qualified to drive
a commercial motor vehicle if that person has no established medical
history or clinical diagnosis of diabetes mellitus currently requiring
insulin for control'' (49 CFR 391.41(b)(3)).
FMCSA established its diabetes exemption program, based on the
Agency's July 2000 study entitled ``A Report to Congress on the
Feasibility of a Program to Qualify Individuals with Insulin-Treated
Diabetes Mellitus to Operate in Interstate Commerce as Directed by the
Transportation Act for the 21st Century.'' The report concluded that a
safe and practicable protocol to allow some drivers with ITDM to
operate CMVs is feasible. The September 3, 2003 (68 FR 52441), Federal
Register notice in conjunction with the November 8, 2005 (70 FR 67777),
Federal Register notice provides the current protocol for allowing such
drivers to operate CMVs in interstate commerce.
These 19 applicants have had ITDM over a range of 4 to 44 years.
These applicants report no severe hypoglycemic reactions resulting in
loss of consciousness or seizure, requiring the assistance of another
person, or resulting in impaired cognitive function that occurred
without warning symptoms, in the past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in the past 5 years. In each case,
an endocrinologist verified that the driver has demonstrated a
willingness to properly monitor and manage his/her diabetes mellitus,
received education related to diabetes management, and is on a stable
insulin regimen. These drivers report no other disqualifying
conditions, including diabetes-related complications. Each meets the
vision requirement at 49 CFR 391.41(b)(10).
The qualifications and medical condition of each applicant were
stated and discussed in detail in the February 4, 2013, Federal
Register notice and they will not be repeated in this notice.
Discussion of Comments
FMCSA received no comments in this proceeding.
Basis for Exemption Determination
Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption
from the diabetes requirement in 49 CFR 391.41(b)(3) if the exemption
is likely to achieve an equivalent or greater level of safety than
would be achieved without the exemption. The exemption allows the
applicants to operate CMVs in interstate commerce.
To evaluate the effect of these exemptions on safety, FMCSA
considered medical reports about the applicants' ITDM and vision, and
reviewed the treating endocrinologists' medical opinion related to the
ability of the driver to safely operate a CMV while using insulin.
Consequently, FMCSA finds that in each case exempting these
applicants from the diabetes requirement in 49 CFR 391.41(b)(3) is
likely to achieve a level of safety equal to that existing without the
exemption.
[[Page 19799]]
Conditions and Requirements
The terms and conditions of the exemption will be provided to the
applicants in the exemption document and they include the following:
(1) That each individual submit a quarterly monitoring checklist
completed by the treating endocrinologist as well as an annual
checklist with a comprehensive medical evaluation; (2) that each
individual reports within 2 business days of occurrence, all episodes
of severe hypoglycemia, significant complications, or inability to
manage diabetes; also, any involvement in an accident or any other
adverse event in a CMV or personal vehicle, whether or not it is
related to an episode of hypoglycemia; (3) that each individual provide
a copy of the ophthalmologist's or optometrist's report to the medical
examiner at the time of the annual medical examination; and (4) that
each individual provide a copy of the annual medical certification to
the employer for retention in the driver's qualification file, or keep
a copy in his/her driver's qualification file if he/she is self-
employed. The driver must also have a copy of the certification when
driving, for presentation to a duly authorized Federal, State, or local
enforcement official.
Conclusion
Based upon its evaluation of the 19 exemption applications, FMCSA
exempts Nicholas C. Bolton (NY), Isaias Gomez (IN), Brandon E. Hamlett
(NV), Douglas F. Keller (MI), Mark R. Loesel (WI), Steven A. Marion
(MA), Jason E. McAnnally (AL), Robert W. Moen (IA), Craig S. Moran
(CA), Wayne A. Ondrusek (PA), Lenicia R. Riley (TX), Mark L. Sandager
(MN), Samuel L. Sergio (MA), Jason L. Shaw (OK), Paul M. Shierk (OR),
Kailey J. Skroko (IN), Samantha K. Tsuchiya (CA), David W. West (MO),
and Eugene Zollner, II (OH) from the ITDM requirement in 49 CFR
391.41(b)(3), subject to the conditions listed under ``Conditions and
Requirements'' above.
In accordance with 49 U.S.C. 31136(e) and 31315 each exemption will
be valid for two years unless revoked earlier by FMCSA. The exemption
will be revoked if the following occurs: (1) The person fails to comply
with the terms and conditions of the 1/exemption; (2) the exemption has
resulted in a lower level of safety than was maintained before it was
granted; or (3) continuation of the exemption would not be consistent
with the goals and objectives of 49 U.S.C. 31136(e) and 31315. If the
exemption is still effective at the end of the 2-year period, the
person may apply to FMCSA for a renewal under procedures in effect at
that time.
Issued on: March 21, 2013.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2013-07459 Filed 4-1-13; 8:45 am]
BILLING CODE 4910-EX-P